StockData
Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc. (HEPA) stock

HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)

Close on Oct 19, 2026Market cap $7.26MP/E –Yield –

Hepion Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Hepion Pharmaceuticals's total debt was $299.58K at Sep 30, 2026. For fiscal 2020 it was $0.

Annual total debt

PeriodPeriod endValueChange
FY2020Dec 31, 2020$0–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Sep 30, 2026$299.58K–
Q1 FY2021CQ1 2021Mar 31, 2021$176.59K–
Q4 FY2020CQ4 2020Dec 31, 2020$0–
Q1 FY2019CQ1 2019Mar 31, 2019$832.90K–

More Hepion Pharmaceuticals figures

See a number that looks wrong?